Bevax

Antineoplastic. Anti VEGF monoclonal antibody. Indicated to treat patients with advanced or metastatic tumors such as: colorectal cancer, lung cancer, glioblastoma, ovary cancer, renal cancer, cervix cancer.

Therapeutic Area
Oncology

Active Ingredient
Bevacizumab

Line
Oncology

Pharmaceutical Forms
1 ampoule with 4 ml solution (100 mg)
1 ampoule with 16 ml solution (400 mg)
Solution 25 mg/ml.

Download Leaflet Descargar